Clinical Trial Update: Pharmacokinetic Study to Evaluate Double-Dose Levonorgestrel Emergency Contraception in Combination With Efavirenz-Based Antiretroviral Therapy or Rifampicin-Containing Anti-Tuberculosis Therapy [Phase 2]

View source ↗

Summary

Phase 2 pharmacokinetic study evaluating double-dose levonorgestrel emergency contraception with efavirenz-based ART or rifampicin-containing TB therapy has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections
• Tuberculosis

Drugs mentioned

• efavirenz-based antiretroviral therapy (efavirenz-based ART)
• levonorgestrel (double-dose emergency contraception) (levonorgestrel)
• rifampicin-containing anti-tuberculosis therapy (rifampicin-containing TB therapy)

Snippet

Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | Conditions: HIV Infections, Tuberculosis | Phase 2 | Status: COMPLETED | Results posted: 2021-11-30